Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

Code · CFR · Title 21 — Food and Drugs · Part 882 — Neurological Devices · § 882.1491

§ 882.1491. Pediatric Autism Spectrum Disorder diagnosis aid.

277 words·~1 min read·/us/cfr/t21/s§ 882.1491·

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

(a)Identification. A pediatric Autism Spectrum Disorder diagnosis aid is a prescription device that is intended for use as an aid in the diagnosis of Autism Spectrum Disorder in pediatric patients.
(b)Classification. Class II (special controls). The special controls for this device are:
(1)Clinical performance testing must demonstrate that the device performs as intended under anticipated conditions of use, including an evaluation of sensitivity, specificity, positive predictive value, and negative predictive value using a reference method of diagnosis and assessment of patient behavioral symptomology.
(2)Software verification, validation, and hazard analysis must be provided. Software documentation must include a detailed, technical description of the algorithm(s) used to generate device output(s), and a cybersecurity assessment of the impact of threats and vulnerabilities on device functionality and user(s).
(3)Usability assessment must demonstrate that the intended user(s) can safely and correctly use the device.
(4)Labeling must include:
(i)Instructions for use, including a detailed description of the device, compatibility information, and information to facilitate clinical interpretation of all device outputs; and
(ii)A summary of any clinical testing conducted to demonstrate how the device functions as an interpretation of patient behavioral symptomology associated with Autism Spectrum Disorder. The summary must include the following:
(A)A description of each device output and clinical interpretation;
(B)Any performance measures, including sensitivity, specificity, positive predictive value
(PPV)and negative predictive value (NPV);
(C)A description of how the cutoff values used for categorical classification of diagnoses were determined; and
(D)Any expected or observed adverse events and complications.
(iii)A statement that the device is not intended for use as a stand-alone diagnostic. [87 FR 80445, Dec. 30, 2022]
Connections1 cite this
Citation graph
cites case law
§ 882.1491
Pediatric Autism Spectrum Disorder diagnosis aid.
Fed. Reg.×1
Cites 0Cited by 1 across 1 source
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.